AU516957B2 - Imidazolylalkyl indoles - Google Patents

Imidazolylalkyl indoles

Info

Publication number: AU516957B2
Authority: AU; Australia
Prior art keywords: imidazolylalkyl; indoles; imidazolylalkyl indoles
Prior art date: 1979-03-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

AU56231/80A

Other versions

AU5623180A (en

Inventor

Peter Edward Cross

Roger Peter Dickinson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Corp SRL

Original Assignee

Pfizer Corp Belgium

Pfizer Corp SRL

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-03-07

Filing date

1980-03-06

Publication date

1981-07-02

1980-03-06 Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium

1980-09-11 Publication of AU5623180A publication Critical patent/AU5623180A/en

1981-07-02 Application granted granted Critical

1981-07-02 Publication of AU516957B2 publication Critical patent/AU516957B2/en

2000-03-06 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AU56231/80A 1979-03-07 1980-03-06 Imidazolylalkyl indoles Ceased AU516957B2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB7908123		1979-03-07
GB7908123		1979-03-07

Publications (2)

Publication Number	Publication Date
AU5623180A AU5623180A (en)	1980-09-11
AU516957B2 true AU516957B2 (en)	1981-07-02

Family

ID=10503707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU56231/80A Ceased AU516957B2 (en)	1979-03-07	1980-03-06	Imidazolylalkyl indoles

Country Status (36)

Country	Link
US (1)	US4273782A (en)
JP (1)	JPS55133380A (en)
KR (1)	KR850000760B1 (en)
AR (1)	AR227015A1 (en)
AT (1)	AT375366B (en)
AU (1)	AU516957B2 (en)
BE (1)	BE882113A (en)
CA (1)	CA1120479A (en)
CH (1)	CH649546A5 (en)
CS (1)	CS253702B2 (en)
DD (1)	DD149525A5 (en)
DE (1)	DE3008632A1 (en)
DK (1)	DK151884C (en)
ES (2)	ES489220A0 (en)
FI (1)	FI66860C (en)
FR (1)	FR2450832A1 (en)
GR (1)	GR67237B (en)
HK (1)	HK89884A (en)
HU (1)	HU184727B (en)
IE (1)	IE49542B1 (en)
IL (1)	IL59524A (en)
IT (1)	IT1218420B (en)
KE (1)	KE3467A (en)
LU (1)	LU82224A1 (en)
MY (1)	MY8500285A (en)
NL (1)	NL182959C (en)
NO (1)	NO152217C (en)
NZ (1)	NZ193052A (en)
PH (1)	PH15198A (en)
PL (1)	PL128296B1 (en)
PT (1)	PT70914A (en)
SE (1)	SE440778B (en)
SG (1)	SG67284G (en)
SU (1)	SU1277894A3 (en)
YU (1)	YU41911B (en)
ZA (1)	ZA801328B (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4414159A (en) *	1980-09-26	1983-11-08	E. I. Du Pont De Nemours & Co.	Vinyl ether monomers and polymers therefrom
US4444775A (en) *	1981-06-22	1984-04-24	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridines
KR840000529A (en) *	1981-07-07	1984-02-25	콘스탄틴 루이스 클레멘트	Method for preparing indole derivative
ZA825413B (en) *	1981-08-26	1983-06-29	Pfizer	Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4460777A (en) *	1981-11-19	1984-07-17	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4478842A (en) *	1981-11-19	1984-10-23	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4539410A (en) *	1982-09-30	1985-09-03	Ciba-Geigy Corporation	N-Substituted-2-(1-imidazolyl)indoles
US4436746A (en)	1982-09-30	1984-03-13	Ciba-Geigy Corporation	Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
AT376436B (en) *	1982-11-05	1984-11-26	Laevosan Gmbh & Co Kg	METHOD FOR PRODUCING NEW THIOPHENE-2CARBONS [UREDERIVATIVES AND PHARMACEUTICALLY COMPATIBLE ACID OR BASE ADDITION SALTS THEREOF
US4511573A (en) *	1983-05-17	1985-04-16	Ciba-Geigy Corporation	3-Substituted-2-(heteroaryl) indoles
DE3786030T2 (en)	1986-03-27	1993-12-02	Merck Frosst Canada Inc	Tetrahydrocarbazole esters.
JPH0832679B2 (en) *	1986-09-05	1996-03-29	理化学研究所	N-phthalicide derivative and method for producing the same
GR871809B (en) *	1986-11-28	1988-03-07	Glaxo Group Ltd	Process for the preparation of tricyclic ketones
AU5279390A (en) *	1989-03-31	1990-11-05	Kyoto Pharmaceutical Industries, Ltd.	New imidazole derivatives, production thereof, and uses thereof as medicines
PT97888B (en) *	1990-06-07	1998-12-31	Zeneca Ltd	PROCESS FOR THE PREPARATION OF HETEROCYCLIC COMPOUNDS DERIVED FROM INDOL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE4023215A1 (en) *	1990-07-21	1992-01-23	Hoechst Ag	New substd. azole derivs. angiotensin II antagonists - for treating hypertension, coronary insufficiency, myocardial infarct, coronary hypertrophy, arteriosclerosis etc.
KR930702334A (en) *	1990-09-13	1993-09-08	데이비드 로버트	Indourea as a 5 hydroxytryptamine receptor antagonist
US5162337A (en) *	1990-10-05	1992-11-10	Merck & Co., Inc.	Animal growth promotion
US5120749A (en) *	1991-02-20	1992-06-09	Abbott Laboratories	Platelet activating antagonists
US5463074A (en) *	1991-12-18	1995-10-31	Schering Corporation	Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
US5538973A (en) *	1992-03-27	1996-07-23	Kyoto Pharmaceutical Industries, Ltd.	Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
EP0597112A4 (en) *	1992-03-27	1994-06-22	Kyoto Pharma Ind	Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor.
JPH0632913U (en) *	1992-09-18	1994-04-28	三洋電機株式会社	Floor heating panel
AU774929B2 (en) *	1998-03-31	2004-07-15	Institutes For Pharmaceutical Discovery, Llc, The	Substituted indolealkanoic acids
RU2296759C2 (en) *	2002-09-12	2007-04-10	Ф.Хоффманн-Ля Рош Аг	N-substituted 1h-indole-5-propionic acids, pharmaceutical composition containing these compounds and their using (variants)
EP1567523B1 (en) *	2002-11-25	2008-08-20	F.Hoffmann-La Roche Ag	Indolyl derivatives
MXPA05006282A (en) *	2002-12-10	2005-08-19	Wyeth Corp	Substituted 3-alkyl and 3-arylalkyl 1h.
GB0324763D0 (en) *	2003-10-23	2003-11-26	Oxagen Ltd	Use of compounds in therapy
CA2564563C (en) *	2004-05-03	2011-07-05	F. Hoffmann-La Roche Ag	Indolyl derivatives as liver-x-receptor modulators
KR20070091607A (en) *	2004-10-12	2007-09-11	디코드 제네틱스, 아이엔씨.	Substituted Bicyclic Compounds Around Sulfonamide for Obstructive Arterial Disease
RU2008110908A (en) *	2005-08-25	2009-09-27	Шеринг Корпорейшн (US)	IMIDAZOLE DERIVATIVES AS A FUNCTIONALLY SELECTIVE ALFA-2C ADRENORE RECEPTORS
GB2431927B (en) *	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) *	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en)	2005-11-04	2011-07-12	Amira Pharmaceuticals, Inc.	5-lipdxygenase-activating protein (FLAP) inhibitors
WO2007137042A2 (en) *	2006-05-16	2007-11-29	Decode Genetics, Ehf.	Process for preparing 7- (acryl0yl) -ind0les
EP2492268A1 (en)	2006-07-22	2012-08-29	Oxagen Limited	Compounds having CRTH2 antagonist activity
TW200920369A (en) *	2007-10-26	2009-05-16	Amira Pharmaceuticals Inc	5-lipoxygenase activating protein (flap) inhibitor
EP2234608A2 (en)	2007-12-11	2010-10-06	Viamet Pharmaceuticals, Inc.	Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
US7750027B2 (en) *	2008-01-18	2010-07-06	Oxagen Limited	Compounds having CRTH2 antagonist activity
RU2503672C2 (en)	2008-01-18	2014-01-10	Оксаген Лимитед	Compounds having crth2 antagonist activity
WO2009093029A1 (en) *	2008-01-22	2009-07-30	Oxagen Limited	Compounds having crth2 antagonist activity
US20100022613A1 (en) *	2008-01-22	2010-01-28	Oxagen Limited	Compounds Having CRTH2 Antagonist Activity
SG190667A1 (en) *	2008-05-23	2013-06-28	Panmira Pharmaceuticals Llc	5-lipoxygenase-activating protein inhibitor
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
JP2014518223A (en) *	2011-06-20	2014-07-28	アルツハイマーズ・インスティテュート・オブ・アメリカ・インコーポレイテッド	Compounds and their therapeutic uses
GB201322273D0 (en)	2013-12-17	2014-01-29	Atopix Therapeutics Ltd	Process
GB201407820D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
GB201407807D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
WO2019191410A1 (en) *	2018-03-29	2019-10-03	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Inhibitors for the β-catenin / t-cell factor protein–protein interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL125443C (en) *	1963-06-06
US3370063A (en) *	1964-10-05	1968-02-20	Mcneilab Inc	Substituted dimethoxy indoles and method of making the same
US3621027A (en) *	1968-03-18	1971-11-16	Endo Lab	1-aminoalkyl-2,6-diaryl 4,5,6,7 tetrahydro-4-oxindales
US3931229A (en) *	1973-08-23	1976-01-06	Warner-Lambert Company	3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles
US4059583A (en) *	1975-11-13	1977-11-22	Mcneil Laboratories, Incorporated	Substituted indoles
AU523536B2 (en) *	1977-08-26	1982-08-05	Wellcome Foundation Limited, The	Imidazoles and methods of preparing them
US4140858A (en) *	1977-12-19	1979-02-20	Warner-Lambert Company	3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
DE2960547D1 (en) *	1978-02-24	1981-11-05	Pfizer Ltd	3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

1980
- 1980-01-31 DK DK042580A patent/DK151884C/en active
- 1980-03-04 HU HU80498A patent/HU184727B/en not_active IP Right Cessation
- 1980-03-04 CS CS801492A patent/CS253702B2/en unknown
- 1980-03-05 NZ NZ193052A patent/NZ193052A/en unknown
- 1980-03-05 LU LU82224A patent/LU82224A1/en unknown
- 1980-03-05 GR GR61368A patent/GR67237B/el unknown
- 1980-03-05 PL PL1980222470A patent/PL128296B1/en unknown
- 1980-03-05 PH PH23726A patent/PH15198A/en unknown
- 1980-03-05 SU SU802891745A patent/SU1277894A3/en active
- 1980-03-05 SE SE8001736A patent/SE440778B/en not_active IP Right Cessation
- 1980-03-05 YU YU614/80A patent/YU41911B/en unknown
- 1980-03-05 IL IL59524A patent/IL59524A/en unknown
- 1980-03-05 FI FI800672A patent/FI66860C/en not_active IP Right Cessation
- 1980-03-05 ES ES489220A patent/ES489220A0/en active Granted
- 1980-03-05 US US06/127,298 patent/US4273782A/en not_active Expired - Lifetime
- 1980-03-06 CH CH1781/80A patent/CH649546A5/en not_active IP Right Cessation
- 1980-03-06 AU AU56231/80A patent/AU516957B2/en not_active Ceased
- 1980-03-06 DE DE19803008632 patent/DE3008632A1/en active Granted
- 1980-03-06 NL NLAANVRAGE8001351,A patent/NL182959C/en not_active IP Right Cessation
- 1980-03-06 AT AT0125780A patent/AT375366B/en not_active IP Right Cessation
- 1980-03-06 PT PT70914A patent/PT70914A/en not_active IP Right Cessation
- 1980-03-06 NO NO800650A patent/NO152217C/en unknown
- 1980-03-06 BE BE0/199699A patent/BE882113A/en not_active IP Right Cessation
- 1980-03-06 IT IT20399/80A patent/IT1218420B/en active
- 1980-03-06 JP JP2856380A patent/JPS55133380A/en active Granted
- 1980-03-06 FR FR8005054A patent/FR2450832A1/en active Granted
- 1980-03-06 CA CA000347143A patent/CA1120479A/en not_active Expired
- 1980-03-06 ZA ZA00801328A patent/ZA801328B/en unknown
- 1980-03-06 IE IE453/80A patent/IE49542B1/en not_active IP Right Cessation
- 1980-03-06 AR AR280198A patent/AR227015A1/en active
- 1980-03-06 DD DD80219495A patent/DD149525A5/en not_active IP Right Cessation
- 1980-03-06 KR KR1019800000931A patent/KR850000760B1/en not_active Expired
- 1980-11-14 ES ES496889A patent/ES496889A0/en active Granted
1984
- 1984-09-21 SG SG67284A patent/SG67284G/en unknown
- 1984-10-05 KE KE3467A patent/KE3467A/en unknown
- 1984-11-15 HK HK898/84A patent/HK89884A/en unknown
1985
- 1985-12-30 MY MY285/85A patent/MY8500285A/en unknown

Also Published As

Publication number	Publication date
ZA801328B (en)	1981-03-25
ES8205789A1 (en)	1982-08-01
DE3008632A1 (en)	1980-10-16
GR67237B (en)	1981-06-25
SE8001736L (en)	1980-09-08
YU61480A (en)	1983-12-31
NO800650L (en)	1980-09-08
JPS55133380A (en)	1980-10-17
FI66860C (en)	1984-12-10
NL8001351A (en)	1980-09-09
IL59524A (en)	1982-11-30
FI66860B (en)	1984-08-31
FI800672A7 (en)	1980-09-08
HU184727B (en)	1984-10-29
AU5623180A (en)	1980-09-11
NO152217C (en)	1985-08-21
JPS6141513B2 (en)	1986-09-16
DE3008632C2 (en)	1988-02-25
AT375366B (en)	1984-07-25
NO152217B (en)	1985-05-13
DK42580A (en)	1980-09-08
AR227015A1 (en)	1982-09-15
PL222470A1 (en)	1980-12-01
FR2450832B1 (en)	1983-04-22
DK151884B (en)	1988-01-11
DD149525A5 (en)	1981-07-15
CS253702B2 (en)	1987-12-17
SE440778B (en)	1985-08-19
CA1120479A (en)	1982-03-23
NZ193052A (en)	1984-07-06
NL182959C (en)	1988-06-16
DK151884C (en)	1988-06-13
PH15198A (en)	1982-09-17
US4273782A (en)	1981-06-16
IT1218420B (en)	1990-04-19
KR830001928A (en)	1983-05-19
ATA125780A (en)	1983-12-15
ES8104278A1 (en)	1981-04-01
IT8020399A0 (en)	1980-03-06
LU82224A1 (en)	1980-06-06
IL59524A0 (en)	1980-06-30
IE49542B1 (en)	1985-10-30
SU1277894A3 (en)	1986-12-15
YU41911B (en)	1988-02-29
HK89884A (en)	1984-11-23
CH649546A5 (en)	1985-05-31
KE3467A (en)	1984-11-09
IE800453L (en)	1980-09-07
ES496889A0 (en)	1982-08-01
KR850000760B1 (en)	1985-05-25
ES489220A0 (en)	1981-04-01
MY8500285A (en)	1985-12-31
SG67284G (en)	1985-03-15
BE882113A (en)	1980-09-08
PL128296B1 (en)	1984-01-31
FR2450832A1 (en)	1980-10-03
PT70914A (en)	1980-04-01

Publication	Publication Date	Title
AU516957B2 (en)	1981-07-02	Imidazolylalkyl indoles
AU544254B2 (en)	1985-05-23	Methods
AU538496B2 (en)	1984-08-16	Methods
AU532879B2 (en)	1983-10-20	1-aryl-2-acylamido-3-fluoro-1-propanols
AU548070B2 (en)	1985-11-21	Arylsulphonyls
AU532626B2 (en)	1983-10-06	Monacolink
AU541091B2 (en)	1984-12-13	Azolyloxy-carboxylic acid -oxy-amides
AU532783B2 (en)	1983-10-13	4-aroyl-imazol-2-ones
AU535632B2 (en)	1984-03-29	Cyclo-octapeptides
AU537592B2 (en)	1984-07-05	Mercaptoacyldipeptides
AU529508B2 (en)	1983-06-09	6-n-propyl-8alpha-methoxymethyl or -methylmercaptomethyl -ergolines
AU533526B2 (en)	1983-12-01	Polyether-polyamines
AU5564380A (en)	1980-08-28	Emulsans
AU532884B2 (en)	1983-10-20	Vinyl-cephalosporins
AU527992B2 (en)	1983-03-31	9-aminoalkylfluorenes
AU532763B2 (en)	1983-10-13	8-aminoalkyl-4-alkylpsoralens
AU539187B2 (en)	1984-09-13	Pyrazinobenzodiazepines
GB2045244B (en)	1983-01-26	3-1-(imidazolylalkyl) indoles
AU533807B2 (en)	1983-12-08	Pyridothienotriazines
AU538025B2 (en)	1984-07-26	N-cyanoimidate
AU5537680A (en)	1980-09-04	Tetrahydrobenzothiazolylimidazolidinones
AU531811B2 (en)	1983-09-08	Thiazolylidene-oxo-propionitriles
AU536556B2 (en)	1984-05-10	Aldehyde-ethers
AU532700B2 (en)	1983-10-13	Diphenylalkanoether
AU528075B2 (en)	1983-04-14	Z-aza-ergolines